Drug Companies Favor Biotech Meds Over Pills, Citing New U.S. Law
Drugmakers are prioritizing complex biotech medicines over treatments that can be given as pills because recent U.S.
Stay updated with breaking news from Dave Ricks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drugmakers are prioritizing complex biotech medicines over treatments that can be given as pills because recent U.S.
By Deena Beasley San Francisco (Reuters) - Drugmakers are prioritizing complex biotech medicines over treatments that can be given as pills because re...
Drugmakers are prioritizing complex biotech medicines over treatments that can be given as pills because recent US legislation gives biologics a longer runway before becoming subject to government price limits.
According to a Virginia-based pollster, Hoosiers want the General Assembly to focus on reducing health care costs, tackling affordable housing and improving education funding.
Eli LIlly is looking to make waves in an important therapeutic area.